IRCT2013071914013N1已完成未知
The effect of DHA supplement on PPAR?- LXRa- ABCA1 pathway in PPAR?2 Pro12Ala genetic variants in type 2 diabetes
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30 years 至 70 years（—）
- 性别
- All
入选标准
- •Type 2 diabetic willing to participate in the study;BMI (kg/m2) between 18.5 to 35; Age from 30 to 60 year
- •Exclusion criteria: Insulin therapy; Thiazolidinediones therapy; Liver, kidney, coagulation and thyroid disorders; Anticoagulation, ant-inflammation and lipid lowering drug consumption; History of Allergic reaction to fish or fish oil; Daily consumption of fish or w3 supplement; Supplementation with vitamin A,D and B6
排除标准
- 未提供
研究者
相似试验
已完成
3 期
The effect of Docosahexaenoic acid on factors influencing vascular thickness and function in diabetic patientsCondition 1: Type 2 Diabetes melitus. Condition 2: Atherosclerosis.non-insulin-dependent diabetesArterial sclerosisIRCT2013071213964N1Tehran University of Medical Sciences72
尚未招募
Unknown
Omega-3 nutrient supplementation and inflammatory and metabolic markers in people with Obesity: a randomized, controlled, double-blind clinical studyRBR-78w4k8cniversidade de São Paulo
已完成
不适用
Effect of combination therapy of EPA and DHA on arterial stiffness in type 2 diabetic patients with hypertriglyceridemiaHypertriglyceridemia with type 2 diabetesJPRN-UMIN000011206Toho University Sakura Medical Center50
已完成
不适用
Effect of EPA/DHA supplementation added on DPP4 inhibitors on lipid and glucose metabolism in patients with type 2 diabetestype 2 diabetesJPRN-UMIN000011169Department of Internal Medicine, Keio University School of Medicine50
已完成
2 期
Influence of DHA-rich Supplement on DHA-status and Health Evolution of Patients With Cystic FibrosisCystic FibrosisNCT00221546University Hospital, Ghent17